Atherosclerosis: The Involvement of Immunity, Cytokines and Cells in Pathogenesis, and Potential Novel Therapeutics
Chang Su(HBIS (China)), Junnan Tang(University of North Carolina at Chapel Hill), Yongzheng Lu(First Affiliated Hospital of Zhengzhou University), Yu Liu(University of Macau), Jiamin Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Yichen Dai(Chinese University of Hong Kong, Shenzhen), Zeyu Wang(Anhui University), Xiaofang Wang(Chinese Academy of Tropical Agricultural Sciences), Jinying Zhang(First Affiliated Hospital of Zhengzhou University), Guozhen Liu(Chinese University of Hong Kong, Shenzhen), Zhaowei Sun(China University of Petroleum, Beijing), Zhen Qin(First Affiliated Hospital of Zhengzhou University), Jiacheng Guo(First Affiliated Hospital of Zhengzhou University), Xiaolin Cui(Chinese University of Hong Kong, Shenzhen), Yachen Hou(Henan University of Technology), Xunde Xian(Home Office)
Cited by 26
Related Papers
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria
|Proceedings of the National Academy of Sciences|2011|379
Aggregation-Induced Emission (AIE), Life and Health
|ACS Nano|2023|348
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
|Journal of Hematology & Oncology|2022|273